PiggyBac transposon-mediated CD19 CAR T
/ Chulalongkorn University
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 24, 2026
Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.
(clinicaltrials.gov)
- P1 | N=3 | Completed | Sponsor: Chulalongkorn University | Recruiting ➔ Completed | Trial completion date: Nov 2025 ➔ Mar 2026 | Trial primary completion date: Nov 2024 ➔ Mar 2026
Trial completion • Trial completion date • Trial primary completion date • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
1 to 1
Of
1
Go to page
1